Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | urotensin 2 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0437 | 0.3311 | 0.4398 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0525 | 0.4361 | 0.581 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0557 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0437 | 0.3311 | 0.443 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0377 | 0.2588 | 0.3461 |
Onchocerca volvulus | 0.0913 | 0.9025 | 0.9285 | |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.018 | 0.0229 | 0.0306 |
Mycobacterium ulcerans | polyketide synthase | 0.0557 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0525 | 0.4361 | 0.5834 |
Loa Loa (eye worm) | hypothetical protein | 0.0882 | 0.8643 | 1 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0165 | 0.0042 | 0.0056 |
Brugia malayi | AMP-binding enzyme family protein | 0.049 | 0.3948 | 0.3948 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0557 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0784 | 0.7476 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0347 | 0.2228 | 0.2941 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0557 | 0.4752 | 0.6337 |
Loa Loa (eye worm) | hypothetical protein | 0.0294 | 0.1592 | 0.0823 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0557 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0429 | 0.3214 | 0.4299 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0557 | 0.4752 | 0.6357 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.049 | 0.3948 | 0.528 |
Mycobacterium ulcerans | thioesterase TesA | 0.0437 | 0.3311 | 0.443 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0374 | 0.2547 | 0.3708 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0784 | 0.7476 | 1 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.034 | 0.2149 | 0.2574 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0422 | 0.3131 | 0.4188 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0525 | 0.4361 | 0.4361 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0422 | 0.3131 | 0.4188 |
Mycobacterium ulcerans | thioesterase | 0.0437 | 0.3311 | 0.443 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0165 | 0.0042 | 0.0056 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0347 | 0.2228 | 0.2981 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0298 | 0.1644 | 0.2199 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0212 | 0.061 | 0.0817 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0422 | 0.3131 | 0.4155 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0946 | 0.9416 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0509 | 0.4168 | 0.5576 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0525 | 0.4361 | 0.5834 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0557 | 0.4752 | 0.6337 |
Mycobacterium ulcerans | polyketide synthase | 0.0525 | 0.4361 | 0.5834 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0557 | 0.4752 | 1 |
Loa Loa (eye worm) | fatty acid synthase | 0.0518 | 0.4277 | 0.4318 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0525 | 0.4361 | 0.581 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0784 | 0.7476 | 1 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0557 | 0.4752 | 0.6357 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0557 | 0.4752 | 0.6357 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.049 | 0.3948 | 0.3889 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0509 | 0.4168 | 0.5576 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0784 | 0.7476 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0347 | 0.2228 | 0.2981 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 450 nM | Displacement of [125I]-U2 from human recombinant urotensin2 receptor expressed in human Chem-2 cells after 4 hrs by scintillation proximity assay | ChEMBL. | 23453841 |
IC50 (binding) | = 950 nM | Antagonist activity at recombinant human urotensin2 receptor expressed in CHO cells assessed as inhibition of urotensin2-stimulated Ca2+ mobilization after 1 hr by FLIPR assay | ChEMBL. | 23453841 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.